Les anticoagulants oraux directs : analyse des accidents iatrogènes dans le service des urgences de l’hôpital de la Conception

Van der Hulle, 2014, Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis, Thromb Haemost, 12, 320, 10.1111/jth.12485 2015 2015 2015 Wittkowsky, 2011, Novel oral anticoagulants and their role in clinical practice, Pharmacotherapy, 31, 1175, 10.1592/phco.31.12.1175 ANSM, 2013 Hanon, 2013, Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people, Arch Crdiovasc Dis, 106, 303, 10.1016/j.acvd.2013.04.001 Stangier, 2008, Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate, Clin pharmacokinet, 47, 285, 10.2165/00003088-200847050-00001 Tamigniau, 2014, Why, when and how to monitor new oral anticoagulants, Rev Med Suisse, 10, 326 ANSM, 2014 Berod, 2014, Pharm Hosp Clin, 49, 176 Rédaction PRESCRIRE : Éviter les effets indésirables par Interactions Médicamenteuses ; comprendre et décider : le Guide 2013. Ten Cate, 2013, New oral anticoagulants: discussion on monitoring and adherence should start now!, Thromb J, 11, 8, 10.1186/1477-9560-11-8 Wilkinson, 2005, Drug metabolism and variability among patients in drug reponse, New Engl J Med, 352, 2211, 10.1056/NEJMra032424 Cascorbi, 2011, P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations, Handb Exp Pharmacol, 201, 261, 10.1007/978-3-642-14541-4_6 Kim, 1999, Interrelationship between substrates and inhibitors of human CYP3A an P-glycoprotein, Phar Res, 16, 408, 10.1023/A:1018877803319 BoehringerIngelheim, 2010 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 ANSM, 2013 Haute Autorité de santé, 2013 Dickneite, 2014, Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?, Thromb Haemost, 111, 189, 10.1160/TH13-05-0431 ANSM, 2014 ANSM, 2014 Diener, 2014, Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage, Expert Rev Neurother, 14, 1019, 10.1586/14737175.2014.945435 Delavenne, 2014, New oral anticoagulants: pharmacological data to know for clinical practice, Rev Med Suisse, 10, 319 HAS, 2015